2022-12-01 2023-11-30 false Capium Accounts Production 1.1 12988096 bus:AbridgedAccounts 2022-12-01 2023-11-30 12988096 bus:FRS102 2022-12-01 2023-11-30 12988096 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 12988096 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 12988096 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12988096 2022-12-01 2023-11-30 12988096 2023-11-30 12988096 bus:RegisteredOffice 2022-12-01 2023-11-30 12988096 core:WithinOneYear 2023-11-30 12988096 core:AfterOneYear 2023-11-30 12988096 bus:Director1 2022-12-01 2023-11-30 12988096 bus:Director1 2023-11-30 12988096 bus:Director1 2021-12-01 2022-11-30 12988096 bus:Director2 2022-12-01 2023-11-30 12988096 bus:Director2 2023-11-30 12988096 bus:Director2 2021-12-01 2022-11-30 12988096 2021-12-01 12988096 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 12988096 2021-12-01 2022-11-30 12988096 2022-11-30 12988096 core:WithinOneYear 2022-11-30 12988096 core:AfterOneYear 2022-11-30 12988096 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 12988096 core:NetGoodwill 2022-12-01 2023-11-30 12988096 core:NetGoodwill 2023-11-30 12988096 core:NetGoodwill 2022-11-30 12988096 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 12988096 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 12988096 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 12988096 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 12988096 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 12988096 core:Non-currentFinancialInstruments 2023-11-30 12988096 core:Non-currentFinancialInstruments 2022-11-30 12988096 core:ShareCapital 2023-11-30 12988096 core:ShareCapital 2022-11-30 12988096 core:RetainedEarningsAccumulatedLosses 2023-11-30 12988096 core:RetainedEarningsAccumulatedLosses 2022-11-30 12988096 dpl:Item1 2022-12-01 12988096 dpl:Item1 2023-11-30 12988096 dpl:Item1 2021-12-01 12988096 dpl:Item1 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12988096


 

 

 

SG MEDICS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 November 2023 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Myrtle Gund Ltd
30 November 2023



....................................................
Myrtle Gund Ltd
248 Lockwood Road

Huddersfield
HD1 3TG
29 August 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Intangible fixed assets 3 606,337    606,337 
606,337    606,337 
Current assets      
Cash at bank and in hand 43,784    43,784 
Creditors: amount falling due within one year (4,662)   (4,662)
Net current assets 39,122    39,122 
 
Total assets less current liabilities 645,459    645,459 
Creditors: amount falling due after more than one year (725,390)   (725,390)
Net assets (79,931)   (79,931)
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account (80,031)   (80,031)
Shareholders' funds (79,931)   (79,931)
 


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 29 August 2024 and were signed on its behalf by:


-------------------------------
Gowardhan KOTRA
Director
2
General Information
SG MEDICS LIMITED is a private company, limited by shares, registered in , registration number 12988096, registration address 16 HALLAM ROAD, ROTHERHAM SOUTH YORKSHIRE, S60 3DA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years.
2.

Average number of employees

Average number of employees during the year was 0 (2022 : 0).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 December 2022 638,250    638,250 
Additions  
Disposals  
At 30 November 2023 638,250    638,250 
Amortisation
At 01 December 2022 31,913    31,913 
Charge for year  
On disposals  
At 30 November 2023 31,913    31,913 
Net book values
At 30 November 2023 606,337    606,337 
At 30 November 2022 606,337    606,337 


3